Apr 22, 2014 3:06pm EDT OPKO Announces Presentation of Data on Long-Acting Oxyntomodulin at Diabetes Conference
Apr 17, 2014 11:22am EDT OPKO Acquires Next Generation Dry Powder Inhaler to Treat Respiratory Disorders
Mar 25, 2014 12:18pm EDT American Urological Association (AUA) Accepts 4Kscore Test Clinical Study for Plenary Presentation at 2014 Annual Meeting
Feb 28, 2014 9:58am EST OPKO's Longer-Acting Clotting Factor VIIa-CTP Receives Orphan Drug Designation in the U.S.